Catalyst
Pit
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
☰
BCDA
BioCardia, Inc.
NASDAQ · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Last close
$1.01
· 2026-09-30
ABOUT
Exchange
NASDAQ
Sector
Healthcare
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Market cap
$15.29M
Country
USA
RECENT INSIDER TRADES
2026-09-30
· Altman Peter
(President and CEO)
· BUY
2026-09-23
· Altman Peter
(President and CEO)
· BUY
2026-09-04
· Altman Peter
(President and CEO)
· BUY
2026-08-18
· Altman Peter
(President and CEO)
· BUY
2026-08-13
· Altman Peter
(President and CEO)
· BUY
INSTITUTIONAL OWNERSHIP
Institutional holders
22
Shares held
1,468,912
Value
$1.80M
Percent of shares outstanding
9.70%
As of quarter end
2026-06-30
RECENT NEWS
BioCardia to present CardiAMP HF II trial design at Heart Failure Society meeting
BioCardia files revised pre-submission with FDA for Helix Catheter approval
BioCardia president and CEO Peter Altman buys $1,030 in shares
BioCardia Confirms Timing and Provides Update on FDA Helix Pre-Submission and PMDA CardiAMP HF Shonin Submission
BioCardia, Inc. · 8-K (8.01,9.01)
Catalyst
Pit
Features
Coming soon
Pricing
Coming soon
Privacy
Terms
Disclaimer
Affiliate Terms
Contact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS